ontario regulation 133/26

made under the

Pharmacy Act, 1991

Made: April 20, 2026
Approved: April 30, 2026
Filed: May 11, 2026
Published on e-Laws: May 11, 2026
Published in The Ontario Gazette: May 30, 2026

Amending O. Reg. 256/24

(GENERAL)

1. (1) Subsection 50 (3) of Ontario Regulation 256/24 is revoked and the following substituted:

(3) A Part A pharmacy technician or an intern technician who meets all the requirements in subsection (6) is authorized to perform an act provided for in paragraph 3 of subsection (1), subject to the terms, conditions and limitations imposed on their certificate of registration.

(2) Paragraph 9 of subsection 50 (4) of the Regulation is revoked.

(3) Subsection 50 (6) of the Regulation is amended by striking out the portion before clause (a) and substituting the following:

(6) A member referred to in subsection (3) may only perform the act of administering the vaccine by injection provided for in paragraph 3 of subsection (1) if the patient is two years of age or older in the case of the influenza vaccine, six months of age or older in the case of Coronavirus (COVID-19) vaccines and five years of age or older in the case of every other vaccine, and if the member,

. . . . .

(4) Clause 50 (6) (c) of the Regulation is revoked.

2. Schedule 3 to the Regulation is amended by adding the following paragraphs:

19.  Tetanus Vaccines.

20.  Diphtheria Vaccines.

21.  Pertussis Vaccines.

3. Schedule 4 to the Regulation is amended by adding the following items:

 

2.1

Calluses and corns

Keratolytic Agents

Salicylic acid

. . . . .

 

12.1

Mild Headache (Tension-Type)

Analgesics

Acetaminophen Acetylsalicylic Acid (ASA) Ibuprofen Naproxen

. . . . .

 

15.1

Pediculosis

Pediculicides

Cyclomethicone Dimeticone Isopropyl Myristate Permethrin Piperonyl butoxide Pyrethrins

. . . . .

 

16.1a	Seborrheic dermatitis (dandruff)	Topical Antifungals	Ciclopirox Ketoconazole Selenium Sulfide Triclosan Zinc Pyrithione
16.1b	Seborrheic dermatitis (dandruff)	Anti-Inflammatory	Roflumilast
16.1c	Seborrheic dermatitis (dandruff)	Topical Corticosteroids	Betamethasone Valerate Hydrocortisone
16.1d	Seborrheic dermatitis (dandruff)	Keratolytic Agents	Coal Tar Salicylic acid

. . . . .

 

17.1	Tinea corporis	Topical Antifungals	Ciclopirox Clotrimazole Ketoconazole Miconazole Terbinafine Tolnaftate Undecylenic acid
17.2	Tinea cruris	Topical Antifungals	Ciclopirox Clotrimazole Ketoconazole Miconazole Terbinafine Tolnaftate Undecylenic acid

. . . . .

 

18.1	Verrucae (warts, excluding face and genitals)	Keratolytic Agents	Salicylic acid
18.2a	Viral Rhinitis, rhinosinusitis	Intranasal Antihistamine	Pheniramine
18.2b	Viral Rhinitis, rhinosinusitis	Decongestants	Phenylephrine Pseudoephedrine
18.2c	Viral Rhinitis, rhinosinusitis	Intranasal Corticosteroids	Mometasone
18.2d	Viral Rhinitis, rhinosinusitis	Intranasal Decongestants	Oxymetazoline Phenylephrine Xylometazoline
18.2e	Viral Rhinitis, rhinosinusitis	Anticholinergics, Nasal	Ipratropium Bromide

. . . . .

 

20.

Xerophthalmia (dry eye disease)

Ophthalmic Lubricants

Carboxymethylcellulose Dextran 70 Glycerin Hydroxypropyl-guar (HP-guar) Hypromellose (hydroxypropyl methylcellulose) Lanolin Mineral oil Petrolatum Polyethylene glycol-400 Polyvinyl alcohol Polyvinyl pyrrolidone (povidone) Propylene glycol

Commencement

4. (1) Except as otherwise provided in this section, this Regulation comes into force on the later of July 1, 2026 and the day this Regulation is filed.

(2) Section 2 comes into force on the day this Regulation is filed.

Made by:
Pris par :

Council of the Ontario College of Pharmacists:
Le Conseil de l’Ordre des pharmaciens de l’Ontario :

Douglas Brown

Board Chair, Ontario College of Pharmacists/Président du Conseil, Ordre des pharmaciens de l'Ontario

Jay O’Neill

Registrar and CEO, Ontario College of Pharmacists/Registrateur et Président-Directeur Général, Ordre des pharmaciens de l'Ontario

Date made: April 20, 2026
Pris le : 20 avril 2026